Sanofi is set to acquire Blueprint Medicines, a US-based biopharmaceutical company specialising in systemic mastocytosis.

Vantive has announced the investment to expand its R&D and manufacturing capabilities, including remote monitoring for kidney ...

Discover a study that found that 22% of patients who underwent radical cystectomy were upstaged at surgery, leading to a ...

DEPRESSION is associated with an increased risk of developing dementia in both midlife and later life, with the risk being ...

A new scoping review reveals how inconsistencies in labeling practices and high bias risk in delirium prediction studies ...

A comprehensive search of electronic databases was conducted up to 6 September 2024 to identify randomised controlled trials ...

A recent photovoice study uncovers the profound psychological and social challenges women face after mastectomy, highlighting ...

Discover a study that highlights the importance of identifying high-risk children through biomarkers and better understanding ...

Lifestyle medicine is a large topic area to cover, but there have been some notable advancements in the areas in which I work ...

Adding nivolumab to chemoradiotherapy may reduce recurrence in patients with resected high-risk head and neck cancer, ...

New phase 3 data show that sacituzumab govitecan plus pembrolizumab delays cancer progression in PD-L1-positive metastatic ...

Learn how dynamic CT detects resistant postpartum haemorrhage, aiding timely interventions and better maternal care.